Stay updated with breaking news from Forefront Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 3,040,000 shares, a drop of 12.1% from the February 28th total of 3,460,000 shares. Based on an average trading volume of 3,800,000 shares, the […]
Codiak BioSciences, Inc. (NASDAQ:CDAK – Get Rating) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 173,800 shares, a growth of 25.6% from the February 28th total of 138,400 shares. Based on an average trading volume of 176,800 shares, the days-to-cover ratio is […]
Codiak BioSciences, Inc. (NASDAQ:CDAK – Get Rating) was the target of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 173,800 shares, a growth of 25.6% from the February 28th total of 138,400 shares. Based on an average daily volume of 176,800 shares, the […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) saw a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 6,300 shares, a decrease of 33.7% from the February 28th total of 9,500 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average […]
StockNews.com lowered shares of CytomX Therapeutics (NASDAQ:CTMX – Get Rating) from a hold rating to a sell rating in a report published on Friday morning. Separately, BMO Capital Markets increased their price target on CytomX Therapeutics from $2.60 to $3.20 and gave the company a market perform rating in a report on Friday, January 6th. […]